Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

Open Access 01-08-2012 | Letter to the Editor

Reply to letter from Mainster M.A. & Turner P.L. titled “Blue light’s benefits vs blue-blocking intraocular lens chromophores”

Authors: James A. Davison, Anil S. Patel, Joao P. Cunha, Jim Schwiegerling, Orkun Muftuoglu

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2012

Excerpt

Dear Editor, …

Davison JA, Patel AS, Cunha JP, Schwiegerling J, Muftuoglu O (2011) Recent studies provide an updated clinical perspective on blue light-filtering IOLs. Graefe’s Arch Clin Exp Ophthalmol 249(7):957–968PubMedCrossRef

Mainster MA (2005) Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol 123:550–555PubMedCrossRef

Mainster MA (2006) Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol 90:784–792PubMedCrossRef

Mainster MA, Turner PL (2010) Blue-blocking IOLs decrease photoreception without providing significant photoprotection. [Viewpoints]. Surv Ophthalmol 55:272–289PubMedCrossRef

Mainster MA, Lang AJ, Lowery MD, Pearson JC, Weaver MA, Fleischer JC, King GA (2007) Ophthalmic devices having a highly selective violet light transmissive filter and related methods. US patent No: 7,278,737 B2

Patel AS, Dacey DM (2009) Relative effectiveness of a blue light-filtering lens for photoentrainment of the circadian rhythm. J Cataract Refract Surg 35:529–539PubMedCrossRef

Cooper HM, Chiquet C, Rieux C, Hut RA, Gronfier C, Claustrat B, Brun J, Denis P (2004) Mid-wavelength monochromatic light is more effective for suppressing plasma melatonin in humans than broadband white light. Invest Ophthalmol Vis Sci 45: E-abstract 4345. Available at http://abstracts.iovs.org/cgi/content/abstract/45/5/4345 Accessed June 23, 2011

Kiser AK, Deschler EK, Dagnelie G (2008) Visual function and performance with blue-light blocking filters in age-related macular degeneration. Clin Exp Ophthalmol 36:514–520CrossRef

Gray R, Perkins SA, Suryakumar R, Neuman B, Maxwell WA (2011) Reduced effects of glare disability on driving performance in patients with blue light filtering intraocular lenses. J Cataract Surg 37:38–44CrossRef

10.

Hammond BR, Renzi LM, Sachak S, Brint SF (2010) Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clin Ophthalmol 4:1465–1473PubMedCrossRef

Title: Reply to letter from Mainster M.A. & Turner P.L. titled “Blue light’s benefits vs blue-blocking intraocular lens chromophores”
Authors: James A. Davison
Anil S. Patel
Joao P. Cunha
Jim Schwiegerling
Orkun Muftuoglu
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2012
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-011-1749-y

At a glance: The STEP trials

Springer Medicine

Reply to letter from Mainster M.A. & Turner P.L. titled “Blue light’s benefits vs blue-blocking intraocular lens chromophores”

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2012

Blue light’s benefits vs blue-blocking intraocular lens chromophores

Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis

Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion

Evaluation of the Icare-ONE rebound tonometer as a self-measuring intraocular pressure device in normal subjects

Effects of long-term topical anti-glaucoma medications on meibomian glands

Surveillance of late-onset bleb leak, blebitis and bleb-related endophthalmitis — a UK incidence study